Geneial Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 7

Geneial General Information

Description

Developer of a rare disease registry platform designed to support patient data collection and research collaboration. The company's platform features registry creation tools, eConsent management, REDCap integration, analytics dashboards, mobile applications, and participant engagement initiatives, enabling advocacy groups and researchers to manage compliant rare disease data collection and research initiatives.

Contact Information

Website
www.geneial.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2762 Parker Oak Pass
  • Missouri City, TX 77459
  • United States
Primary Industry
Other Healthcare Technology Systems
Other Industries
Medical Records Systems
Vertical(s)
Corporate Office
  • 2762 Parker Oak Pass
  • Missouri City, TX 77459
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Geneial Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 01-Aug-2026 Completed Generating Revenue
6. Accelerator/Incubator 01-May-2023 Completed Generating Revenue
5. Secondary Transaction - Private 30-Mar-2023 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
3. Grant 22-Sep-2022 Completed Generating Revenue
2. Early Stage VC 01-Jun-2021 Completed Generating Revenue
1. Grant 01-Jan-2021 $3K Completed Generating Revenue
To view Geneial’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Geneial Patents

Geneial Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023069467-A1 Privacy-preserving data aggregation and sharing system Inactive 19-Oct-2021
EP-4315129-A1 Hardware-accelerated homomorphic encryption in marketplace platforms Pending 27-Mar-2021
EP-4315129-A4 Hardware-accelerated homomorphic encryption in marketplace platforms Pending 27-Mar-2021
US-20240160771-A1 Hardware-accelerated homomorphic encryption in marketplace platforms Pending 27-Mar-2021
WO-2022213048-A1 Hardware-accelerated homomorphic encryption in marketplace platforms Inactive 27-Mar-2021 G06F21/72
To view Geneial’s complete patent history, request access »

Geneial Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Geneial Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hill Capital Corporation Growth/Expansion Minority
MatchPlay Ventures Venture Capital Minority
National Institutes of Health Government
Creative Destruction Lab Accelerator/Incubator
The National Human Genome Research Institute Government
You’re viewing 5 of 7 investors. Get the full list »

Geneial FAQs

  • When was Geneial founded?

    Geneial was founded in 2020.

  • Where is Geneial headquartered?

    Geneial is headquartered in Missouri City, TX.

  • What is the size of Geneial?

    Geneial has 5 total employees.

  • What industry is Geneial in?

    Geneial’s primary industry is Other Healthcare Technology Systems.

  • Is Geneial a private or public company?

    Geneial is a Private company.

  • What is Geneial’s current revenue?

    The current revenue for Geneial is .

  • Who are Geneial’s investors?

    Hill Capital Corporation, MatchPlay Ventures, National Institutes of Health, Creative Destruction Lab, and The National Human Genome Research Institute are 5 of 7 investors who have invested in Geneial.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process